CompPharma looked at current trends within the workers’ compensation pharmacy landscape and found payers are looking for more actionable data from their PBMs.

Opioid overprescription continues to present critical obstacles in the workplace. This National Comp 2022 panel will delve into the costs and benefits of long-term non-pharmacological pain management approaches that could help end the opioid crisis.

Two top docs in the workers’ comp arena bust key myths the industry must contend with surrounding cannabis use amid the substance’s legal momentum.

Each year will bring a new class of medications onto the radar of pharmacy benefit managers, here’s what they’re watching now.

The dangers of dual prescribing and the sometimes staggering differential in the cost of prescription medications were two notable findings in a study by WCRI.

This guide can help you understand the regulations in your state.

Physical therapy and pain management intervention proved productive in replacing opioids as methods to control pain in injured workers.

Employers need to prepare for a wave of new laws legalizing cannabis.

Find out more about psychotropic drugs, their off-label use, and how the COVID-19 pandemic can teach workers’ comp professionals more about the injured worker experience.

The use of a host of strategies and tools, spurred on by the pandemic, is poised to face down mental health challenges in injured workers.

Advanced technologies such as artificial intelligence (AI) and natural language processing (NLP), along with data analytics and system integration, support stronger claims processes that bring out the best of what claims teams can offer injured workers.

The opioid misuse crisis continues to negatively impact the lives of patients while costing our health care system billions of dollars. This is why it still deserves our focus.

Join myMatrixx’s Phil Walls and The Hartford’s Adam Seidner as they explore alternative approaches to opioid pain management in workers’ compensation claims.

At a digital session produced by the National Comp conference, industry leaders will share how pharmacy and settlement programs can work together to produce better outcomes.

Unaddressed behavioral health factors can drive up costs for payers and expose injured workers to delayed return-to-work and painkiller addiction.

Despite regulation meant to curb abuse of physician dispensing, it’s still a common practice and presents both safety and financial risks. 

While PBMs should be helping payers negotiate drug prices, these common overcharges could prevent workers’ comp insurers and self-insureds from getting the best deals.

COVID-19 may be making it difficult for chronic pain patients to access care. Here’s what workers’ comp can do to help.

CBD is being hailed as a solution for everything from chronic pain to the opioid epidemic. But what do we really know about the cannabinoid?

Direct messaging capability connects providers and pharmacies with the information they need to deliver optimal patient care.